Gilead Sciences (GILD) Tax Provisions (2009 - 2026)

Gilead Sciences (GILD) has reported Tax Provisions for 18 consecutive years, with $559.0 million the latest figure, recorded in Q1 2026.

• Tax Provisions for Q1 2026 came in at $559.0 million, up 67.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 35.58% YoY), and the FY2025 annual result was $1.3 billion, up 509.48% from the prior year.
• Tax Provisions was $559.0 million for Q1 2026 at Gilead Sciences, up from -$450.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $646.0 million in Q3 2022 and troughed at -$450.0 million in Q4 2025.
• Average Tax Provisions over 5 years is $247.5 million, with a median of $368.0 million recorded in 2022.
• Year-over-year, Tax Provisions tumbled 303.42% in 2024 and surged 298.32% in 2025.
• Over 5 years, Tax Provisions stood at $398.0 million in 2022, then plunged by 40.45% to $237.0 million in 2023, then soared by 62.45% to $385.0 million in 2024, then plunged by 216.88% to -$450.0 million in 2025, then surged by 224.22% to $559.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $559.0 million in Q1 2026, -$450.0 million in Q4 2025, and $589.0 million in Q3 2025.